Trial intelligence / Profile preview

LSD and 5-HT2A Receptor Role in Self-Perception and Meaning

NCT02451072Completed

Sponsor
Psychiatrische Universitätsklinik Zürich
Start
Mar 2015
Primary completion
Jan 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of Lysergide, sponsored by Psychiatrische Universitätsklinik Zürich. Primary endpoint: fMRI brain activity (Blood-Oxygen-Level Dependent signal) at 160 minutes. Started Mar 2015; status: completed.

02

Drugs

Lysergide

Beyond the preview

Go deeper on NCT02451072.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02451072.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call